跳至主要内容
临床试验/CTRI/2025/02/080034
CTRI/2025/02/080034尚未招募2 期

The Role of Manasika Bhavas in etiopathogenesis of Uccharaktachapa (Essential Hypertension) and its management with Pushkar muladi churna and Shirodhara

Dr Mohd Irfan Ahmad Quraishi1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年2月18日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
1. Routine haematological investigation such as Hb TC DC ESR .

研究概览

简要总结

The whole research work will be summarized and conclusion will be made on the basis of the observation which will be done on the subjective and objective parameters. Result will be analyzed statically & discussed accordingly

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
20.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Criteria for the selection of the patients will be chiefly based on the criteria suggested
  • Known cases of hypertension.
  • Patients between the age 20-70 years
  • Willing to participate in the study and informed consent.

排除标准

  • • Patients suffering from hypertension along with I.H.D., C.H.D., C.A.D., coarctation of aorta • Renal failure • Endocrine diseases • Hypertension with cerebral complications e.g. hypertensive encephalopathy, cerebral haemorrhage, convulsive seizure • Malignant hypertension etc.

结局指标

主要结局

1. Routine haematological investigation such as Hb TC DC ESR .

时间窗: 4 weeks

2. Biochemical tests like blood urea serum creatinine serum cholesterol triglyceride HDL and fasting blood sugar and post prandial blood sugar.

时间窗: 4 weeks

3. Microscopic and routine examination of urine

时间窗: 4 weeks

4. Microscopic and routine examination of stool.

时间窗: 4 weeks

5. ECG and X-ray chest wherever required.

时间窗: 4 weeks

次要结局

  • For the assessment of the therapy, The following scoring pattern will be followed.(1 MONTH)

研究者

发起方
Dr Mohd Irfan Ahmad Quraishi
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Mohd Irfan Ahmad Quraishi

S G M P G Ayurvedic college and hospital Saheri Ghazipur

研究点 (1)

Loading locations...

相似试验